Bills · 119th Congress · H.R. 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
IntroducedConfirmed from the official record
Sponsored by Gregory F. Murphy RRepublican, introduced . Policy area, as Congress files it: Health.
Status is read from the official actions by their Library of Congress codes: Became Public Law (36000) or a law number on the bill reads "Became law"; Vetoed (31000) reads "Vetoed"; Presented to President (28000) reads "Sent to the President"; passed or agreed to in the House (8000) and in the Senate (17000) reads "Passed both chambers"; one of them alone reads "Passed the House" or "Passed the Senate" ("Agreed to" for a resolution); reported to the House (5000) or the Senate (14000) reads "Reported by committee"; anything else reads "Introduced".
Source: Congress.gov data service (Library of Congress). Text versions: our copies of govinfo.gov’s files. Our copy was saved October 14, 2026.
Cosponsors
68 cosponsors.
Text
| Version | Date | Our copy |
|---|---|---|
| Introduced in House | Read our copyThe official file |
Actions
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House
- Introduced in House
Committees
- Ways and Means Committee (House)Referred To, February 21, 2025
- Energy and Commerce Committee (House)Referred To, February 21, 2025
Hearings
We hold hearing records only for bills that became law.
Who lobbied on this bill
Confirmed from the official record38 lobbying reports name H.R. 1492, for 30 clients.
| Client | Registrant | Amount for the whole quarter | Lobbyists named for this issue | Filed | Report |
|---|---|---|---|---|---|
| BAYER CORPORATION (CONSOLIDATED REPORT) | BAYER CORPORATION (CONSOLIDATED REPORT)Second quarter of 2026 | $1,820,000reported as expenses |
| Open the report | |
| NOVARTIS | DLA PIPER LLP (US)Second quarter of 2026 | $60,000reported as income |
| Open the report | |
| AMGEN INC | AMGEN, INC.Second quarter of 2026 | $2,440,000reported as expenses |
| Open the report | |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC.Second quarter of 2026 | $1,440,000reported as expenses |
| Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICASecond quarter of 2026 | $7,360,000reported as expenses |
| Open the report | |
| SOLENO THERAPEUTICS, INC. | SOLENO THERAPEUTICS, INC.Second quarter of 2026 | $70,000reported as expenses |
| Open the report | |
| PHRMA | WILLIAMS AND JENSEN, PLLCSecond quarter of 2026 | $50,000reported as income |
| Open the report | |
| NATIONAL ALLIANCE ON MENTAL ILLNESS | NATIONAL ALLIANCE ON MENTAL ILLNESSSecond quarter of 2026 | $20,000reported as expenses |
| Open the report | |
| PHRMA | MONUMENT ADVOCACYSecond quarter of 2026 | $90,000reported as income |
| Open the report | |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INCSecond quarter of 2026 | $710,000reported as expenses |
| Open the report | |
| THE ALS ASSOCIATION | THE ALS ASSOCIATIONSecond quarter of 2026 | $30,000reported as expenses |
| Open the report | |
| GENENTECH USA, INC. | AVENUE SOLUTIONSSecond quarter of 2026 | $50,000reported as income |
| Open the report | |
| NOVARTIS | NOVARTISSecond quarter of 2026 | $1,410,000reported as expenses |
| Open the report | |
| CHRONIC CARE POLICY ALLIANCE | CHRONIC CARE POLICY ALLIANCESecond quarter of 2026 | The report gives no amount |
| Open the report | |
| NEUROCRINE BIOSCIENCES, INC | NEUROCRINE BIOSCIENCES, INCSecond quarter of 2026 | $940,000reported as expenses |
| Open the report | |
| PUBLIC CITIZEN | PUBLIC CITIZENSecond quarter of 2026 | $99,577reported as expenses |
| Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | THE MCMANUS GROUPSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| ACADIA PHARMACEUTICALS | ACADIA PHARMACEUTICALSSecond quarter of 2026 | $700,000reported as expenses |
| Open the report | |
| GILEAD SCIENCES, INC. | THE MCMANUS GROUPSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| PTC THERAPEUTICS, INC. | PTC THERAPEUTICS, INC.Second quarter of 2026 | $170,000reported as expenses |
| Open the report | |
| HARMONY BIOSCIENCES | HARMONY BIOSCIENCESSecond quarter of 2026 | $180,000reported as expenses |
| Open the report | |
| MERCK & CO. INC. | THE NICKLES GROUP, LLCSecond quarter of 2026 | $70,000reported as income |
| Open the report | |
| NOVO NORDISK, INC. | THE NICKLES GROUP, LLCSecond quarter of 2026 | $80,000reported as income |
| Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | CROSSROADS STRATEGIES, LLCSecond quarter of 2026 | $50,000reported as income |
| Open the report | |
| TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) | TIBER CREEK GROUPSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | ADVANCED POLICY CONSULTING, LLCSecond quarter of 2026 | $40,000reported as income |
| Open the report | |
| NOVARTIS, INC. | TODD STRATEGY GROUPSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.)Second quarter of 2026 | $890,000reported as expenses |
| Open the report | |
| LUNDBECK LLC | LUNDBECK LLCSecond quarter of 2026 | $180,000reported as expenses |
| Open the report | |
| HEALTHCARE INSTITUTE OF NEW JERSEY | HEALTHCARE INSTITUTE OF NEW JERSEYSecond quarter of 2026 | $47,670reported as expenses |
| Open the report | |
| PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | E3 STRATEGIC CONSULTING GROUPSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| SANOFI U.S. SERVICES, INC. | MARSHALL & POPP, LLCSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | MARSHALL & POPP, LLCSecond quarter of 2026 | $40,000reported as income |
| Open the report | |
| PFIZER, INC. | MARSHALL & POPP, LLCSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| GENENTECH, INC. | MARSHALL & POPP, LLCSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| AMGEN USA INC. | MARSHALL & POPP, LLCSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | LMH STRATEGIC SOLUTIONSSecond quarter of 2026 | $30,000reported as income |
| Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AEGIS LLCSecond quarter of 2026 | $60,000reported as income |
| Open the report |
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together, rounded to the nearest $10,000. A report under $5,000 states no figure. It is not the amount spent on one bill.
Reports read: 0 of 1 quarters read in full (2026-Q2). With no registered key the service allows 15 requests a minute, so this covers the latest quarter only. With a key it covers four.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
All saved lobbying reports that name H.R. 1492
Contributions from these lobbyists and firms to the sponsor and cosponsors
| To | Reported by | Paid to, as reported | Amount | Date |
|---|---|---|---|---|
| Donald G. Davis DDemocratCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | DON DAVIS FOR NCHonoree: Davis, Don | $2,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | LUNDBECK LLC EMPLOYEE POLITICAL ACTION COMMITTEEfiled by LUNDBECK LLC, a registrant that filed a lobbying report naming this bill (same LDA registrant number 400426042) | DON DAVIS FOR NCHonoree: Don Davis | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | PEOPLE IN RURAL AREAS TRANSFORM ELECTIONS (PIRATE) PACHonoree: Rep. Don Davis | $2,000 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | TEAM AMERICA - BRINGING AMERICA TOGETHER PACHonoree: Rep. Brian Fitzpatrick | $5,000 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | BRIAN FITZPATRICK FOR ALL OF USHonoree: Fitzpatrick, Brian | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | DON DAVIS FOR NCHonoree: Davis, Don | $3,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | LUNDBECK LLC EMPLOYEE POLITICAL ACTION COMMITTEEfiled by LUNDBECK LLC, a registrant that filed a lobbying report naming this bill (same LDA registrant number 400426042) | DON DAVIS FOR NCHonoree: Don Davis | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | NOVARTIS CORPORATION POLITICAL ACTION COMMITTEEfiled by NOVARTIS, a registrant that filed a lobbying report naming this bill (same LDA registrant number 9204) | DON DAVIS FOR NCHonoree: Don Davis | $5,000 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | BRIAN FITZPATRICK FOR ALL OF USHonoree: Rep. Brian Fitzpatrick | $2,500 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | BRIAN FITZPATRICK FOR ALL OF USHonoree: Rep. Brian Fitzpatrick | $2,500 | Open the report |
| Donald G. Davis DDemocratCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $5,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | DON DAVIS FOR NCHonoree: Davis, Don | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | GLAXOSMITHKLINE LLC PAC (GSK PAC)filed by GSK (FKA GLAXOSMITHKLINE INC.), a registrant that filed a lobbying report naming this bill (same LDA registrant number 16293) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $2,500 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | NEUROCRINE BIOSCIENCES INC.PACfiled by NEUROCRINE BIOSCIENCES, INC, a registrant that filed a lobbying report naming this bill (same LDA registrant number 401105485) | TEAM AMERICA - BRINGING AMERICA TOGETHER PACHonoree: BRIAN FITZPATRICK | $3,500 | Open the report |
| Donald G. Davis DDemocratCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $1,500 | Open the report |
| Donald G. Davis DDemocratCosponsor | PHRMA BETTER GOVERNMENT COMMITTEEfiled by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA, a registrant that filed a lobbying report naming this bill (same LDA registrant number 31350) | DON DAVIS FOR NCHonoree: Davis, Don | $1,000 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | SELFfiled by NICHOLAS UEHLECKE, a lobbyist named on this bill's lobbying reports (same LDA lobbyist number 109746) | BRIAN FITZPATRICK FOR ALL OF USHonoree: U.S. Representative Brian Fitzpatrick | $2,500 | Open the report |
| Donald G. Davis DDemocratCosponsor | PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)filed by PTC THERAPEUTICS, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 401105813) | DON DAVIS FOR NCHonoree: Rep. Don Davis (D) | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | NOVARTIS CORPORATION POLITICAL ACTION COMMITTEEfiled by NOVARTIS, a registrant that filed a lobbying report naming this bill (same LDA registrant number 9204) | DON DAVIS FOR NCHonoree: Don Davis | $4,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $1,000 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | NOVARTIS CORPORATION POLITICAL ACTION COMMITTEEfiled by NOVARTIS, a registrant that filed a lobbying report naming this bill (same LDA registrant number 9204) | BRIAN FITZPATRICK FOR ALL OF USHonoree: Brian Fitzpatrick | $1,000 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | BRIAN FITZPATRICK FOR ALL OF USHonoree: Fitzpatrick, Brian | $2,500 | Open the report |
| Donald G. Davis DDemocratCosponsor | LUNDBECK LLC EMPLOYEE POLITICAL ACTION COMMITTEEfiled by LUNDBECK LLC, a registrant that filed a lobbying report naming this bill (same LDA registrant number 400426042) | DON DAVIS FOR NCHonoree: Don Davis | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | SELFfiled by BRITTANY HERNANDEZ, a lobbyist named on this bill's lobbying reports (same LDA lobbyist number 107303) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $500 | Open the report |
| Donald G. Davis DDemocratCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | DON DAVIS FOR NCHonoree: Davis, Don | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | DON DAVIS FOR NCHonoree: Davis, Don | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | AMGEN PACfiled by AMGEN, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 3867) | DON DAVIS FOR NCHonoree: Davis, Don | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | GLAXOSMITHKLINE LLC PAC (GSK PAC)filed by GSK (FKA GLAXOSMITHKLINE INC.), a registrant that filed a lobbying report naming this bill (same LDA registrant number 16293) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | NOVARTIS CORPORATION POLITICAL ACTION COMMITTEEfiled by NOVARTIS, a registrant that filed a lobbying report naming this bill (same LDA registrant number 9204) | DON DAVIS FOR NCHonoree: Don Davis | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | BAYER US LLC EMPLOYEE POLITICAL ACTION COMMITTEE (BAYERPAC)filed by BAYER CORPORATION (CONSOLIDATED REPORT), a registrant that filed a lobbying report naming this bill (same LDA registrant number 5632) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $5,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | DON DAVIS FOR NCHonoree: Rep. Don Davis | $2,500 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | NEUROCRINE BIOSCIENCES INC.PACfiled by NEUROCRINE BIOSCIENCES, INC, a registrant that filed a lobbying report naming this bill (same LDA registrant number 401105485) | BRIAN FITZPATRICK FOR ALL OF USHonoree: BRIAN FITZPATRICK | $3,500 | Open the report |
| Donald G. Davis DDemocratCosponsor | BOEHRINGER INGELHEIM USA CORPORATION POLITICAL ACTION COMMITTEE BOEHRINGER PACfiled by BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC, a registrant that filed a lobbying report naming this bill (same LDA registrant number 292972) | DON DAVIS FOR NCHonoree: Rep Don Davis | $1,000 | Open the report |
| Brian K. Fitzpatrick RRepublicanCosponsor | JOHNSON & JOHNSON POLITICAL ACTION COMMITTEEfiled by JOHNSON & JOHNSON SERVICES, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 20686) | BRIAN FITZPATRICK FOR ALL OF USHonoree: Rep. Brian Fitzpatrick | $5,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | PHRMA BETTER GOVERNMENT COMMITTEEfiled by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA, a registrant that filed a lobbying report naming this bill (same LDA registrant number 31350) | DON DAVIS FOR NCHonoree: Davis, Don | $1,000 | Open the report |
| Donald G. Davis DDemocratCosponsor | LUNDBECK LLC EMPLOYEE POLITICAL ACTION COMMITTEEfiled by LUNDBECK LLC, a registrant that filed a lobbying report naming this bill (same LDA registrant number 400426042) | DON DAVIS FOR NCHonoree: Don Davis | $1,000 | Open the report |
Contribution reports are read for 2 of the 69 sponsors and cosponsors so far.
Lobbyists and registrants report their political contributions twice a year (form LD-203). A contribution is listed here when the report was filed by a lobbyist named on this bill's lobbying reports or by a registrant that filed one of them, and its payee is the member's own committee as the FEC lists it, under the exact-name rule. The contribution's date is as reported and can fall before or after the lobbying.